Page 63 - Pharma

SMS Pharma to invest about Rs 1000 cr in AP

The company plans to scale down manufacturing operations in Telangana

NPPA withdraws price cap guidelines for 108 medicines

After a directive from the government, NPPA withdraws guidelines that reduced prices of 108 medicines in anti-diabetes and cardiovascular segments

Germany's Merck to acquire Sigma-Aldrich for $17 billion

Acquisition expands Merck Millipore's global reach, increasing the company's presence in North America and adding exposure to fast-growing Asian markets

Cipla signs licensing deal with Salix Pharma for Rifaximin complexes

Under the agreement, Salix will have exclusive rights under certain patent applications in the 'Rifaximin Complexes' patent family controlled by Cipla

Bayer to realign business; decides to focus only on life sciences biz

The company plans to float MaterialScience as separate company, and focus only on life sciences businesses - HealthCare and CropScience

Sun Pharma inks licensing pact with US-based Merck for tildrakizumab

Indian firm will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of $ 80 million

Germany's DiaSys to buy Piramal Enterprises' diagnostics equipment trading unit

The deal is worth Rs 13 crores

Hetero Group exits pharmacy retailing; Sales biz to Apollo Hospitals

Acquisition will help Apollo Pharmacy to consolidate its operations in the three states - Telengana, Andhra Pradesh and Tamil Nadu

Ramco to supply Dabur IT solutions for HR operations

Dabur employees across 16 countries to leverage Ramco's comprehensive HR & talent management solution with payroll & analytics

Aurobindo Pharma receives USFDA approval for amoxicillin

The ANDA was approved out of unit 12, semi-synthetic Penicillin facility in Hyderabad

Lupin joins hand with Germany's Merck Serono to tap emerging markets

Lupin joins hand with Germany's Merck Serono to tap emerging markets

AstraZeneca sets up global tech centre in Chennai to cut IT cost

While this is company's first such centre globally, it plans to establish two more technology centres in San Francisco (USA) and in Eastern Europe

Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms

Seven India-based firms - Ranbaxy, Cipla, Mylan, Cadila, Hetero, Sequent and Strides Arcolab - will produce hepatitis C medicines for distribution in 91 developing countries

Lupin inks pact to market US-based Salix Pharma's drugs in Canada

The addition of Salix Pharma's product portfolio opens up growth opportunities for Lupin in Canada, where it is in the process of establishing its presence

Malaysia's IHH Healthcare to buy Fortis' stake in RadLink for $ 108.5 mn

Fortis Healthcare has divested stake in the Singapore based RadLink to focus on Indian operation

Venus Pharma inks pact with Mylan for marketing meropenem in 3 European countries

The distribution & out-licensing agreement will enable Venus Remedies to market meropenem in Denmark, Sweden and Finland for five years

Cipla partners with S&D Pharma to tap Czech Republic and Slovakia

Under the collaboration, Cipla will be driving its respiratory product portfolio in both Czech Republic and Slovakia

Cadila Pharma plans for manufacturing facility in Bahrain

The company has already received approvals from Gulf Central Committee for Drug Registrations for many of its drugs

India and Bangladesh to join hands for traditional medicines

The MoU will provide a structured frame work for cooperation between the two countries for the promotion of Indian traditional systems of medicine and homeopathy in Bangladesh

Cipla buys two facilities of Okasa for Rs 100 cr

While one facility belonging to Okasa Private Limited is located in Goa, another owned by Okasa Pharma is situated in Satara (Maharashtra)